Concepts (55)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluorodeoxyglucose F18 | 2 | 2017 | 91 | 0.270 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 206 | 0.260 |
Why?
|
| Atherosclerosis | 2 | 2017 | 148 | 0.230 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 46 | 0.210 |
Why?
|
| Comparative Effectiveness Research | 1 | 2012 | 49 | 0.190 |
Why?
|
| Macrophages | 2 | 2017 | 1017 | 0.180 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 30 | 0.180 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 184 | 0.170 |
Why?
|
| Deoxyglucose | 1 | 2017 | 31 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 28 | 0.140 |
Why?
|
| Glutamine | 1 | 2017 | 47 | 0.140 |
Why?
|
| Monocytes | 2 | 2021 | 346 | 0.140 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 31 | 0.140 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 73 | 0.130 |
Why?
|
| Glucose | 2 | 2016 | 449 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 324 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 659 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 19 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 61 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2014 | 285 | 0.100 |
Why?
|
| Inflammation | 1 | 2016 | 1116 | 0.080 |
Why?
|
| Lipid Peroxides | 1 | 2021 | 11 | 0.050 |
Why?
|
| Boron Compounds | 1 | 2021 | 19 | 0.050 |
Why?
|
| Glycine | 1 | 2021 | 46 | 0.050 |
Why?
|
| Granulocytes | 1 | 2021 | 69 | 0.050 |
Why?
|
| Bortezomib | 1 | 2021 | 56 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2021 | 129 | 0.040 |
Why?
|
| Mice | 3 | 2017 | 10362 | 0.040 |
Why?
|
| Autoradiography | 1 | 2017 | 53 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1389 | 0.030 |
Why?
|
| Aorta | 1 | 2017 | 107 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 180 | 0.030 |
Why?
|
| Glutaredoxins | 1 | 2014 | 1 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2014 | 3 | 0.030 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2014 | 33 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 54 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 42 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 19839 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 305 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 137 | 0.030 |
Why?
|
| Transfection | 1 | 2014 | 678 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2108 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 588 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 882 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1305 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 1158 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2004 | 0.020 |
Why?
|
| United States | 1 | 2012 | 7662 | 0.020 |
Why?
|
| Humans | 3 | 2021 | 60999 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2083 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3663 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 2485 | 0.020 |
Why?
|
| Male | 1 | 2014 | 28463 | 0.010 |
Why?
|